Home » Repackager Gets FDA Warning for Mislabeling Drug Strength
Repackager Gets FDA Warning for Mislabeling Drug Strength
The FDA has sent contract repackager Shamrock Medical a warning letter for labeling drugs with the wrong strength.
Outsourcing Pharma
Outsourcing Pharma
Upcoming Events
-
07May
-
14May
-
30May